Abstract

BackgroundThe diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. However, the profiles of tau isoforms in CSF of CJD patients remain unknown. Here, we prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD.Methodology/Principal FindingsSequences encoding exon-2, exon-3 and exon-10 of human tau protein were cloned into a prokaryotic expression vector pGEX-2T. Using recombinant fusion proteins GST-E2, GST-E3 and GST-E10, three tau exon-specific antibodies were elicited. Reliable specificities of the prepared antibodies were obtained after a serial of purification processes, not only in recognizing the tau peptides encoded by exon-2, -3 and -10, but also in distinguishing six recombinant tau isoforms by Western blot and ELISA. Three predominant tau-specific bands were observed in CSF samples with the exon-specific and the commercial tau antibodies, respectively, showing different reactive profiles between the groups of probable CJD and non-CJD. A 65 KD band was detected only in the CSF samples from probable CJD patients, especially with the antibodies against exon-2 (Anti-tE2) and exon-10 (Anit-tE10). The appearances of 65 KD band in CSF correlated well with positive 14-3-3 in CSF and typical abnormality in EEG. Such band was not observed in the CSF samples of six tested genetic CJD patients.Conclusions/SignificanceThree exon-specific polyclonal antibodies were successfully prepared. Based on these antibodies, different CSF tau profiles in Western blots were observed between the groups of probable CJD and non-CJD. A disease-specific tau band emerged in the CSF samples from probable sporadic CJD, which may supply a new biomarker for screening sporadic CJD.

Highlights

  • Creutzfeldt-Jakob disease (CJD) is a rapidly progressive and fatal disorder of the central nervous system believed to be caused by prion [1]

  • The profiles of tau isoforms in cerebrospinal fluid (CSF) of CJD patients remain unknown, possibly due to lacking of tau isoform- or exon-specific antibodies

  • Our study provide the reliable human tau exon-specific polyclonal antibodies and the 65 KD tau-specific band may be used as a new biomarker for screening sporadic CJD

Read more

Summary

Introduction

Creutzfeldt-Jakob disease (CJD) is a rapidly progressive and fatal disorder of the central nervous system believed to be caused by prion [1]. A definite diagnosis can only be made by neuropathological examination and demonstration of the pathological isoform of the prion protein (PrPSc) in central nervous tissues, either at biopsy or autopsy [3]. The diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. The profiles of tau isoforms in CSF of CJD patients remain unknown. We prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call